Patent Grant
8512360
1. Field of the Invention
The invention relates to a conduit that is placed in fluid communication with a target vessel and a source of blood, and methods and devices for placing the conduit in fluid communication with the target vessel and the source of blood.
2. Description of the Background Art
Despite the considerable advances that have been realized in cardiology and cardiovascular surgery, heart disease remains the leading cause of death throughout much of the world. Coronary artery disease, or arteriosclerosis, is the single leading cause of death in the United States today. As a result, those in the cardiovascular field continue to search for new and improved treatments.
Coronary artery disease is currently treated by interventional procedures such as percutaneous transluminal coronary angioplasty (PTCA), coronary stenting and atherectomy, as well as surgical procedures including coronary artery bypass grafting (CABG). The goal of these procedures is to reestablish or improve blood flow through occluded (or partially occluded) coronary arteries, and is accomplished, for example, by enlarging the blood flow lumen of the artery or forming a bypass that allows blood to circumvent the occlusion. What procedure(s) is used typically depends on the severity and location of the blockage(s). When successful, these procedures restore blood flow to myocardial tissue that had not been sufficiently perfused due to the occlusion.
An alternative, recently proposed treatment places the target vessel in fluid communication with a heart chamber containing blood, for example, the left ventricle. Blood flows from the ventricle into a conduit that is in fluid communication with the target vessel. Some of the challenges associated with these procedures include delivering and deploying the conduit in the patient's body, and in particular properly positioning the conduit with respect to the heart chamber and the target vessel, as well as obtaining beneficial flow characteristics through the target vessel.
The improvement and refinement of existing treatments and the search for new treatments are indicative of the significant effort that continues to be expended in order to develop better and more efficient ways of revascularizing the heart.
Accordingly, there remains a need in the art for improved methods and devices that are capable of being used quickly, easily and in a repeatable manner to carry out cardiac revascularization.
The invention provides methods and devices for placing a conduit in fluid communication with a source of blood and a target vessel. One preferred method according to the invention includes steps of placing a conduit having a lumen in fluid communication with a heart chamber containing blood, placing the conduit in fluid communication with the lumen of a target vessel and securing the conduit to the target vessel, delivering blood from the heart chamber into the conduit during at least one phase of the heart cycle, and permitting the blood to flow from the conduit into the lumen of the target vessel in more than one direction.
Another preferred method is similar to the above-described method but includes the additional step of permitting the blood to exit the conduit unrestricted and in more than one direction in the lumen of the target vessel.
Another preferred method includes steps of providing a conduit including first and second portions that are disposed transverse to each other and have lumens in fluid communication, the first conduit portion including at least one inlet and the second conduit portion including at least one outlet. The inlet of the first conduit portion is placed in fluid communication with a heart chamber containing blood to allow blood to enter the lumen of the first conduit portion, and the outlet of the second conduit portion is placed in fluid communication with the lumen of a target vessel at a selected location in the target vessel to allow blood to flow into the lumen of the target vessel from the second conduit portion. The second conduit portion is secured to the target vessel at the selected location while substantially not moving the second conduit portion along a longitudinal axis of the target vessel.
Still another preferred method includes steps of providing a conduit including first and second portions each of which has a lumen, wherein the first and second conduit portions are disposed transverse to each other with the lumens in fluid communication and the second conduit portion is at least partially collapsible, and placing the lumen of the first conduit portion in fluid communication with a heart chamber containing blood. The second conduit portion is at least partially collapsed and positioned within the lumen of a target vessel at a selected location in the target vessel, and is then expanded within the target vessel lumen at the selected location to secure the second conduit portion to the target vessel in fluid communication therewith.
Yet another preferred method includes steps of determining a thickness of the patient's myocardium adjacent a heart chamber containing blood, placing a conduit having a lumen in the myocardium with the lumen of the conduit in fluid communication with the heart chamber containing blood, placing the conduit in fluid communication with the lumen of a target vessel and securing the conduit to the target vessel, and delivering blood from the heart chamber into the conduit and allowing blood to exit the conduit and enter the target vessel in more than one direction.
One preferred device constructed according to the invention includes a conduit having first and second portions, wherein the first and second conduit portions each have an axis and a lumen through which blood may flow, the axes of the first and second conduit portions being transverse to each other. The first conduit portion is configured to be placed in fluid communication with a heart chamber containing blood and includes at least one inlet configured to be at least partially positioned in myocardial tissue without collapsing during myocardial contraction, whereas the second conduit portion is configured to be at least partially positioned within the target vessel and includes at least one outlet adapted to deliver blood to the target vessel. The inlet of the first conduit portion is more rigid than the outlet of the second conduit portion.
Another preferred device includes a conduit having first and second portions that are transverse to each other and have lumens in fluid communication. The first conduit portion has a longitudinal axis and is sized and configured to be placed in fluid communication with a heart chamber containing blood, and the second conduit portion has a longitudinal axis and is sized and configured to be placed at least partially within a target vessel in a patient's vascular system to deliver blood to the target vessel. The second conduit portion has first and second ends adapted to be positioned in the target vessel, and the longitudinal axis of the first conduit portion crosses the longitudinal axis of the second conduit portion at a location that is spaced different distances from the first and second ends of the second conduit portion.
Another preferred device includes a conduit having first and second portions having respective axes that are transverse to each other, the first conduit portion having a free end configured to be placed in fluid communication with a heart chamber containing blood, and the second conduit portion having two free ends that are configured to be positioned at least partially within the lumen of a target vessel in the patient's vascular system. The conduit is formed at least in part of a molded thermoset or thermoplastic material having a predetermined amount of flexibility to permit the second portion of the conduit to be flexed for placement within the lumen of a target vessel.
The invention also provides devices and methods for delivering a conduit configured to be placed in fluid communication with a target vessel and a source of blood. One preferred delivery device includes a support shaft having a length, and a sheath having a length, a lumen, and a wall with at least one opening extending into the sheath lumen. The support shaft is sized and configured to be at least partially positioned in the sheath lumen so as to contact the sheath wall and substantially block the opening by preventing communication with the sheath lumen via the opening. The support shaft is movable within the sheath lumen to selectively block or unblock the opening in the sheath wall. A conduit is placed on the sheath and, with the opening unblocked, delivers blood into the sheath lumen for perfusing a vessel into which the distal end of the sheath is positioned. As a result, the device may be used to deliver blood to the tissue during deployment of the conduit, thereby minimizing ischemic time for tissue that heretofore was not perfused while carrying out the procedure.
Another preferred delivery device is adapted to deliver a conduit for placing a target vessel in fluid communication with a source of blood, the conduit including first and second transverse portions each of which has an axis and a lumen. The first conduit portion includes at least one inlet configured to be placed in fluid communication with a heart chamber containing blood, and the second conduit portion includes at least one outlet configured to be at least partially positioned within the lumen of a target vessel to deliver blood to the target vessel. The delivery device includes a shaft with a lumen and at least one opening extending into the lumen, and the second conduit portion is mounted on the shaft. The shaft opening is movable into and out of alignment with the lumen of the first conduit portion, and is moved into alignment with the lumen of the first conduit portion to deliver blood to the shaft lumen.
The invention will be better understood from the following detailed description of preferred embodiments thereof, taken in conjunction with the accompanying drawing figures, wherein:
The present invention provides a conduit that is placed in a patient's body to establish a flow path between a source of blood and a target vessel, as well as methods and device for deploying the conduit. In a preferred embodiment, the source of blood is a heart chamber containing oxygenated blood and the target vessel is a coronary vessel (artery or vein). It will be recognized, however, that the invention may be used to form a blood flow path between other hollow body structures. Also, as used herein, source of blood refers to any blood-containing structure, while oxygenated blood refers to blood containing some level of oxygen.
The lumen of the target vessel may be partially or completely obstructed by an occlusion and the conduit placed to form a flow path that bypasses the occlusion. Alternatively or additionally, the conduit may be used to create a supplemental blood flow path that feeds into the target vessel to augment blood flow (native or other) already present in the vessel.
The conduit of the invention may be configured in various manners. In its most preferred form, the conduit includes a first conduit portion having at least one inlet adapted to be placed in communication with a source of blood and a second portion having at least one outlet adapted to be placed in communication with the lumen of a target vessel. The first and second conduit portions may be defined by a single unitary member or several members that are attached or formed into a desired configuration. The first and second conduit portions are transverse to each other and have lumens that meet at a junction. For example, the first and second conduit portions have respective axes that extend transversely to each other to form a predetermined angle, the angle preferably being within a desired range that achieves acceptable flow characteristics.
Referring to FIGS. 1 and 1A-1C, a conduit constructed according to one preferred embodiment of the invention is indicated generally by the reference numeral 10 and includes a first conduit portion 12 and a second conduit portion 14. The first conduit portion 12 has an inlet 16 that is placed in fluid communication with a source of blood, and the second conduit portion 14 has a pair of outlets 18 that are placed in fluid communication with a target vessel. It will be appreciated that the first conduit portion 12 may have more than one inlet and the second conduit portion 14 may have one, two or more outlets. The first and second conduit portions 12, 14 have lumens in fluid communication with each other.
The illustrated conduit 10 is generally T-shaped with the first and second conduit portions 12, 14 meeting at a junction 20 such that their respective axes a, b are substantially perpendicular. It should be noted, though, that according to the invention the axes a, b of the first and second conduit portions 12, 14 could be disposed non-perpendicularly. For example, as discussed further below, rather than forming a 90° (or substantially 90°) angle, the axes a, b could extend transversely to each other to form an acute or obtuse angle (depending on whether the angle is measured from the left or right side of the axis a, as viewed in
The first conduit portion 12 of the illustrated conduit 10 has a free end 22 defining the inlet 16 while the second conduit portion 14 has a pair of free ends 24 defining the outlets 18. The free ends 22, 24 may be integral extensions of their respective conduit portions or they may comprise separate members secured to the conduit. One or more of the free ends 22, 24 may have ends cut, beveled or tapered (or otherwise configured) for easier introduction into the target vessel. The end 24 of the conduit portion 14 is preferably formed of a flexible, relatively atraumatic material (e.g., as discussed below) that will not damage the endothelial cells lining the intimal surface of the target vessel, particularly during placement of the device.
The inlet 16 or outlets 18 may be located on the conduit 10 at a position(s) other than those shown in the Figures, e.g., at one or more points along the length of the conduit. Similarly, in the illustrated embodiment the first conduit portion 12 (axis a) is offset in that it does not bisect the second conduit portion 14 (axis b); this provides the second conduit portion with different size legs extending away from the first conduit portion. Configuring the target vessel portion of the conduit 10 with shorter and longer legs may be useful in introducing the conduit into the target vessel. It should nonetheless be recognized that the first conduit portion 12 may be centrally located along the axis b of the second conduit portion 14 to provide legs of equal length, or it may be offset from the axis b a greater distance than shown in
According to a preferred aspect of the invention, the conduit is provided with a reinforcing component having sufficient strength to ensure that the conduit remains open during use by preventing or reducing the likelihood of the conduit kinking or collapsing. The reinforcing component may be integrally formed with the conduit or it may comprise a separate member secured thereto. One embodiment of a reinforcing component 26 is shown in
In the illustrated embodiment, the spacing, as well as the size and material of construction, of the coils 28 may be used to determine the amount of structural support provided by the reinforcing component 26. As such, these variables may be selected to produce a conduit having desired characteristics. For example, one of the first and second conduit portions 12, 14 may be made more rigid or flexible than the other by varying the pitch of the coils, the thickness of the wire forming the coils, the material forming the coils, etc., on the portions. Further, the reinforcing component 26 may comprise a single coil, a first coil for the first conduit portion and a second coil for the second conduit portion, a first coil for the first conduit portion and two separate coils for the two free legs of the second conduit portion, etc. Finally, it will be noted that the reinforcing component may have a non-coiled configuration, e.g., a stent or stent-like construction, a braided structure, etc., and may comprise one or multiple members. Exemplary materials include metals or alloys, such as titanium, stainless steel or nitinol, and non-metals, such as polymers or other synthetic materials.
The second conduit portion 14 is preferably relatively flexible to allow it to yield slightly when placed in the target vessel and follow the contour of the target vessel (not shown in
It will be appreciated that the size of the conduit will vary depending on the application. Referring to
According to another preferred embodiment of the invention, the second conduit portion comprises a tubular member that is only partially closed about its circumference, as opposed to a tubular member that is entirely closed about its circumference (as is the embodiment of
The first conduit portion 32 has an inlet 36 adapted to be placed in communication with a source of blood, while the second conduit portion 34 has a pair of outlets 38 for directing blood into the target vessel. The first and second conduit portions 32, 34 meet at a junction 40 having a desired amount of flexibility. For example, the first conduit portion 32 may be more rigid than the second conduit portion 34, while the second conduit portion 34 is more rigid than the junction 40. The first conduit portion has a free end 42 defining the inlet 36, and the second conduit portion has two free ends 44 defining the outlets 38. The conduit 30 is provided with a reinforcing component 46 including coils 48 that essentially correspond to the coils 28 of the reinforcing component 26 described above with respect to the embodiment of
Referring to
One benefit of the embodiment shown in
Moreover, this embodiment of the invention is particularly useful in treating the coronary arteries of patient's suffering from arteriosclerosis. That is, the inner or posterior wall of a diseased coronary artery will typically be covered with stenosis or plaque; as a result, contacting this area with a device may lead to various problems, such as dislodging stenotic material or damaging any healthy tissue that still exists. This embodiment provides conduits that are positioned within the lumen of the artery without contacting much of the diseased inner artery wall.
This is in contrast to a conduit having a portion that substantially or completely covers the luminal surface of the wall of the target vessel, thereby covering the inner vessel wall and restricting or blocking flow between the vessel and any diagonal branches or septal perforators. This aspect of the invention is described further in connection with the Figures below which illustrate exemplary methods of using conduits constructed according to the invention. Nonetheless, the conduit of the invention may be positioned transmurally if desired.
The illustrated conduits 10, 30, 50, comprises a single, unitary piece of material (excepting the reinforcing component) that has been formed into a desired configuration. This construction may be preferable to minimize the risk of material separation or other adverse effects to the structural integrity of the conduit. Nonetheless, the conduit of the invention may comprise several pieces of material secured together. Similarly, the reinforcing component may comprise a structural member integrally formed with or coupled to the conduit, or a reinforcing material added to or impregnated in the material forming the conduit.
An exemplary conduit formed of discrete pieces of material is designated by reference numeral 60 in
The first conduit portion 62 of this embodiment has an opposite end 76 which is bifurcated into two flaps 78 each of which is secured to the conduit portion 64 by any of the aforementioned means. The edges of the flaps 78 may be tapered or feathered (as shown) to make a smooth transition with the exterior of the second conduit portion 64, thereby minimizing the amount of material to be introduced into the lumen of the target vessel. It also may be preferable to minimize the wall thickness of the material used to further reduce the amount of material that must be accommodated when the second conduit portion is placed in the target vessel lumen, without sacrificing preferential blood flow characteristics or the structural integrity of the conduit.
Each reinforcing component 92 preferably has a beveled, slightly enlarged end 94, e.g., as a barb, for easy introduction into the target vessel lumen, although only one of the components 92 may be beveled and/or enlarged. Each component 92 also has a step 96 for receiving a suture (not shown) or other fastening means that may be used to enhance attachment between the second conduit portion 84 and the target vessel. It will be appreciated that the specific construction of the reinforcing components 92 and the conduit 80 may be different from that shown, e.g., grooves, slots, resilient collars, roughened surfaces, etc.
The conduit 100 is constructed such that the reinforcing components 114 do not come into direct contact with the luminal surface of the target vessel wall. As shown in
The device 128 is preferably capable of withstanding myocardial contraction during systole so that the conduit 120 remains open during use. The construction and use of the device 128 may be in accordance with the teachings of co-pending, commonly-owned application Ser. No. 09/304,140, filed on May 3, 1999, and entitled “Methods and Devices for Placing a Conduit in Fluid Communication with a Target Vessel,” the entire subject matter of which application is incorporated herein by reference. It will be recognized that the first conduit portion could be secured to tissue by other means, for example, suture, fasteners, clamps, clips, etc.
Specifically, the first conduit portion 132 extends away from the second conduit portion 134 at an angle θ which, in the illustrated embodiment, is approximately 45°. It may be desirable to angle the first and second conduit portions with respect to each other to achieve different flow characteristics, the particular configuration shown in
It should be recognized that the embodiments of
The conduit 220 (
The multiple bends in the embodiments of
The conduits of the invention may be formed of any material suitable for use in a blood-contacting application, for example, synthetic vascular graft materials such as expanded polytetrafluoroethylene (PTFE) and polyethylene terephthalate (Dacron). Other suitable synthetic materials include polyurethanes, such as Tecoflex, polycarbonate polyurethane—PCPU, such as Biospan (Corethane), and silicone, such as MED-4850, MED-6640, and MED-gumstock, all commercially available from NuSil Technology of Carpinteria, Calif. The conduit may also be formed of metal or a metallic alloy such as titanium, stainless steel, and nickel titanium. Finally, it should be noted that the conduit could comprise a tissue graft, for instance, a saphenous vein graft harvested from the patient, an allograft or a xenograft. It will also be appreciated that the conduit may comprise any of the aforementioned materials alone or in combination. Also, the conduits may be provided with means for detecting its position, e.g., radiopaque markers, during or after placement of the conduit in the target vessel, thereby allowing the user to confirm the position of and blood flow through the conduit.
The reinforcing component of the invention is preferably formed of any biocompatible material that will provide the conduit with a desired amount of structural support. Examples of suitable materials include Dacron, or polyethylene terephthalate (PET), Nylon, titanium, stainless steel, nickel titanium, etc. The reinforcing component could take various forms, including the coiled structure shown in
The conduit may also be constructed to minimize or prevent kinking or collapsing without incorporating a reinforcing component, for example, by coating or impregnating the conduit with a material that provides a desired amount of structural rigidity, such as silicone, polyurethane, PTFE, or another polymer, which would not adversely affect the flexibility or structural integrity of the conduit. For example, a coating could be placed on the interior of the conduit to maintain the conduit-blood interface while providing a strain relief-type structure to minimize or prevent kinking. The coating could, however, also be located on the exterior of the conduit (in addition to or instead of the exterior). The conduit may be provided with additional coatings selected to provide particular qualities, for example, antithrombogenic, antimicrobial lubricious, etc., coatings.
The conduit of the invention is preferably relatively flexible so that it may bend or flex during use, although it may be stiff or substantially rigid if desired. The degree of flexibility (or rigidity) imparted to the conduit may vary depending on the particular application and user preference. As an example, in a coronary application the conduit portion placed in the coronary vessel may comprise a material having a Shore hardness in the range of from about 80A to about 55D, this range being preferable because it provides sufficient structural integrity while allowing some flexibility for easier deployment.
In addition to, or in lieu of, providing the conduit with a strain relief element to counteract collapse or kinking, the conduit (or portion of the conduit) may be specifically formed to prevent kinking, for instance, by imparting a preformed bend to one or more desired areas of the conduit, as exemplified by the conduits 140, 150 shown in
Turning to
In the illustrated and preferred embodiments, the conduit is secured to the target vessel by a substantially suture-free attachment; thus, the attachment is not a conventional hand-sewn anastomosis created by suturing the members together. Although some suture may be used, the conduit is preferably coupled to the target vessel by means other than a typical, hand-sewn sutured connection. It will nonetheless be appreciated that the invention may be practiced using suture to secure (partially or completely) the conduit to the target vessel.
In any case, it may be desirable to first measure the thickness of the myocardium, either approximately or precisely, at the area that will receive the device 128 (or the distal segment of the first conduit portion 242). The device 128 may then be placed with its ends properly positioned with respect to the left ventricle and the exterior of the myocardium. Any suitable means for determining the thickness of the myocardium may be used prior to placing the conduit 240. For example, an instrument having markings may be inserted through the myocardium to gauge the myocardial thickness. The instrument, for example, a probe, may have a member on its distal end that is engaged with the endocardium, thereby allowing the user to read the markings disposed adjacent the exterior of the heart. Alternatively, an instrument having a flashback lumen may be used so that entry into the heart chamber is indicated or verified by a blood flash, the instrument having markings that may be read to determine myocardial thickness or verify entry into the source of blood (or the target vessel). Other means for determining myocardial thickness include transesophageal echocardiography (TEE), magnetic resonance imaging, CT scanning and electronic probes.
The second conduit portion 244 includes two outlets 246 and may be placed into the lumen of the LAD through an incision I and, if desired, secured in place by suture S. It should be noted that if the occlusion O is not complete (or if blood from collateral vessels feeds into the LAD proximal to the conduit 240), the outlet 246 that is proximal to the first conduit portion 242 (the outlet to the left in
The second conduit portion 244 will typically be placed in the target vessel distal to the occlusion by a distance that permits easier introduction into the lumen, as opposed to entering a diseased or stenosed section of the vessel. This results in a space located between the occlusion O and the conduit outlet 246 that is disposed nearest the occlusion (the outlet to the left in
Accordingly, the preferred embodiments of the invention utilize conduits that are configured to deliver blood into the target vessel in multiple directions to fully revascularize the myocardial tissue perfused by the vessel. As shown in
The multiple outlets in the preferred conduit permit subsequent access to the conduit (i.e., post procedure) by delivering a guidewire or catheter percutaneously through the patient's vascular system. For example, the catheter may be delivered into the coronary vessel and moved past the occlusion, if possible, and then used to guide a device to the conduit location, e.g., a plaque ablation or removal device.
In an application utilizing the left ventricle as the blood source, such as that depicted in
During diastole, the pressure in the left ventricle is at its minimum, approximately 5-10 mm Hg, while the pressure in the LAD is approximately 80 mm Hg. This pressure differential results in blood being drawn from the LAD into the left ventricle, which would seemingly counteract the delivery of blood to the LAD during systole. It is believed, however, that this backflow of blood into the left ventricle (which may be characterized as “steal” in that blood is being taken from the coronary artery) does not prevent adequate perfusion of the myocardial tissue fed by the distal LAD. In the case of a partial proximal obstruction in the LAD, any blood flowing from the aorta that is stolen into the left ventricle should not prevent adequate revascularization insofar as the aorta may be considered an infinite source. In the case of a complete obstruction in the LAD, any blood that is stolen into the left ventricle will be taken from the distal LAD; however, testing of the inventive conduits has shown that the myocardial tissue is adequately perfused despite a complete proximal obstruction in the LAD. Adequately perfused means that a threshold level of oxygenated blood is being delivered to the myocardial tissue to allow the heart to function within acceptable limits.
The conduits of the invention could be provided with a check valve to prevent backflow of blood into the left ventricle. This design, though, is presently not as preferred as a non-valved conduit. One significant benefit provided by a non-valved conduit is that blood flow through the conduit is essentially constant, although in different directions, which prevents hemostasis in the conduit. As such, not using a valve and allowing backflow through the conduit prevents or reduces the likelihood of thrombosis (clotting) in the conduit, which is a primary concern with any device (like a valve) that is placed in a blood flow path. Consequently, the washing effect provided by blood flowing through the conduit is believed to obviate thrombosis or thrombosis-related problems. This is in contrast to a valved conduit that closes during diastole and thus results in blood remaining stationary in the conduit during a phase of the heart cycle.
As noted above, the LAD is only one example of a coronary vessel that may be treated according to the invention.
A conduit 250 is shown deployed to communicate the left ventricle LV and the LAD, while a conduit 252 is shown deployed so as to communicate the left ventricle LV and the PDA. The conduits 250, 252 are constructed as described above with respect to previous embodiments and include devices 128 that penetrate the epicardium EP, the endocardium EN and the myocardium M to communicate with the left ventricle LV. Those skilled in the art will appreciate that the diagonal D and the obtuse marginal OM represent additional coronary vessels that could be coupled to conduits placed in communication with the left ventricle LV. As such, it will be recognized that the target vessels shown in
The conduit of the invention may be introduced into the lumen of the target vessel via any suitable means. One preferred method is shown in
It will be noted that the conduit 260 is deployed to its final position without substantially moving the second conduit portion 264 within the target vessel lumen. That is, the conduit is not moved relative to the vessel wall by an amount that risks damaging the intimal surface of the vessel wall. Alternatively, the conduit may be deployed by sliding the distal end of the second conduit portion distally, placing the proximal end in the vessel lumen, and sliding the conduit proximally to anchor it to the vessel (in a manner somewhat similar to that used by surgeons to place a perfusion bridge in a coronary artery during cardiac surgery).
The second conduit portion 264 will remain in location in the target vessel due to the anchoring provided by the proximal and distal legs of the second conduit portion 264. The attachment between the conduit and the target vessel should provide a hemostatic seal; therefore, if necessary, additional means for securing the conduit to the vessel may be used, for example, suture (as shown in
The collapsible conduit retaining instruments 266 (
Another embodiment of a device and method for deploying a conduit in a target vessel according to the invention will be described with respect to
The delivery device 280 includes an inner component preferably in the form of an obturator 282 and an outer component preferably in the form of a sheath 284 (
A variation of the delivery device shown in
The conduit of the invention is preferably sized and configured to form a blood flow path that is equal or substantially equal to the blood flow path defined by the native vessel. In other words, the conduit preferably defines an inner diameter that equals or substantially equals (e.g., 90% of) the inner diameter of the native vessel. As a result, when placed in the target vessel the conduit allows a sufficient volume of blood flow. If the target vessel is a coronary artery, this ensures that blood will flow to the distal vasculature and perfuse the myocardial tissue.
The overall size and relative dimensions of the conduit will vary depending on the application. For sake of example, with reference to
Similarly, the diameter D1 (and in particular the inner diameter) of the first conduit portion 12 may vary but is preferably within the range of from about 2 mm to 10 mm, and more preferably within the range of from 3 mm to 4 mm. The diameter D2 of the second conduit portion 14 will be dictated primarily by the size of the lumen of the target vessel being treated. As an example, for use in coronary vessels, the diameter D2 (and in particular the inner diameter) of the second conduit portion 14 is preferably within the range of 1 mm to 4 mm. It will be recognized, however, that these ranges are exemplary as the invention encompasses conduits the dimensions of which fall outside such ranges by an amount that will not preclude their use in a desired application (cardiovascular or other).
The conduit of the invention also may be characterized by the relative dimensions of the respective conduit portions. For example, with reference to
The conduit of the invention may be manufactured by various processes. It is currently preferred to mold the conduit of (or fabricate the conduit from) a material having desired blood interface qualities as well as a desired combination of flexibility and column strength. Manufacturing processes and materials for forming the conduits disclosed herein are disclosed in co-pending, commonly owned application Ser. No. 09/394,119, filed on Sep. 10, 1999 and entitled “Methods and Devices for Manufacturing a Conduit for Use in Placing a Target Vessel in Fluid Communication With a Source of Blood,” the entire subject matter of which application is incorporated herein by reference.
The type of procedure (e.g., open chest, minimally invasive, percutaneous, etc.) that is used to deploy the conduit of the invention may vary depending on the vessels being treated and user preference. As an example, a minimally invasive procedure may be used to deploy the conduit on a beating heart using various devices and methods for stabilizing all or a portion of the heart. Also, the conduits may be coupled to the target vessel other than as specifically shown herein. While several collapsible conduits are illustrated along with exemplary methods for deploying them in a target vessel, it will be appreciated that the invention encompasses securing non-collapsible conduits to the vessel. For instance, the second conduit portion may be a non-collapsible, tubular member that is placed in the target vessel lumen after first dilating the vessel wall, and then is retained by allowing the vessel wall to move back and snugly engage the exterior of the second conduit portion.
Moreover, the conduit may be used with a component that secures and preferably seals the conduit to the wall of the target vessel. For example, the component could comprise a sleeve or cuff member that partially or completely surrounds the conduit adjacent the target vessel wall. The vessel wall is effectively sandwiched between the component and the intraluminal portion of the conduit, i.e., the conduit portion located in the vessel lumen (the second conduit portion in the above embodiments). The component exerts sufficient force toward the intraluminal portion of the conduit to secure the assembly to the target vessel while providing adequate hemostasis at the attachment site. The component could be separate from or integral with the conduit, and could be constructed according to the teachings of co-pending, commonly owned application Ser. No. 09/393,130, filed on Sep. 10, 1999 and entitled “Anastomotic Methods and Devices for Placing a Target Vessel in Fluid Communication With a Source of Blood,” the entire subject matter of which application is incorporated herein by reference.
It should also be noted that the conduits of the invention may be introduced into a target vessel in various ways. For example, in the illustrated embodiment, the second conduit portion is inserted through a surgical incision in the vessel wall. An alternative arrangement includes a delivery device on which the conduit is mounted, the device having a permanent or detachable incising element with a sharpened tip for penetrating the wall of the target vessel in conjunction with introducing the conduit. Another arrangement uses a sheath that restrains a collapsible conduit and is removed to deploy the conduit.
Additionally, the conduits of the invention are preferably, though not necessarily, placed with the portion in the myocardium spaced from the portion in the coronary vessel. That is, the channel passing through the myocardium is not beneath or immediately adjacent the vessel. Nonetheless, as shown above the conduit may be positioned transmurally in myocardial tissue directly or substantially beneath or adjacent the vessel. One benefit of the former method is that the conduit (or delivery device supporting the conduit) is introduced through the outer or anterior vessel wall to engage the lumen; it is not passed through the inner or posterior vessel wall, which tends to be more diseased than the outer wall.
It may be desirable to utilize a conduit delivery device having a portion surrounding the conduit to protect the conduit material prior to and during deployment. The device may have a bore that, in addition to receiving the aforementioned optional incising element so that may be extended and retracted, is configured to act as a flashback lumen and indicate when the device has entered a lumen containing blood, for example, a coronary artery or heart chamber. Of course, additional members, for example, a guide wire or guide catheter, may be used to deliver the conduit.
The conduits of the invention may be provided with a valve or other means for controlling or regulating blood flow. Suitable valves, as well as means for measuring myocardial thickness or verifying entry into the heart chamber, are disclosed in application Ser. No. 09/023,492, filed on Feb. 13, 1998, and entitled “Methods and Devices Providing Transmyocardial Blood Flow to the Arterial Vascular System of the Heart,” the entire subject matter of which has been incorporated herein by reference. Likewise, the conduits may be provided with a reservoir for retaining and discharging blood in a desired manner.
The conduits and delivery devices of the invention may be sized and configured differently from that specifically illustrated in the Figures. For instance, the cross-section of one or more portions of the conduit may be noncircular, e.g., elliptical to better match the profile of the target vessel. As a further example, the delivery device may be relatively short with the shaft assembly substantially rigid for use in an open-chest procedure. Alternatively, the device may be configured for use in either a minimally invasive or endosvascular procedure, wherein the actuators for controlling the device components are located adjacent the proximal end of the device to allow remote deployment of the conduit, for example, as disclosed in the aforementioned, co-pending, commonly-owned application Ser. No. 09/304,140.
It will be appreciated that the features of the various preferred embodiments of the invention may be used together or separately, while the illustrated methods and devices may be modified or combined in whole or in part. As an example, more than one conduit may be coupled to a manifold that is placed in communication with one source of blood so as to deliver blood to multiple target vessels. The conduits and devices of the invention may include removable or detachable components, could be formed as disposable instruments, reusable instruments capable of being sterilized, or comprise a combination of disposable and reusable components.
Further, it will be understood that the embodiments may be used in various types of procedures, for example, an open surgical procedure including a median sternotomy, a minimally invasive procedure utilizing one or more relatively small access openings or ports, or an endovascular procedure using peripheral access sites. Also, endoscopes or thoracoscopes may be used for visualization if the procedure is performed through very small ports. The different embodiments may be used in beating heart procedures, stopped-heart procedures utilizing cardiopulmonary bypass (CPB), or procedures during which the heart is intermittently stopped and started.
It will be recognized that the invention is not limited to the illustrated applications. For example, the inventive conduits may be used in a CABG procedure by being coupled to an autologous conduit, e.g., a saphenous vein graft (or a nonautologous vessel such as a xenograft, etc.). Further, the conduit could be coupled to a native artery, such as one of the internal mammary arteries, and then secured to the target vessel. Further still, the conduit may be coupled to an existing CABG graft that has partially or completely occluded over time by plugging the second conduit portion into the wall of the graft to communicate with the graft lumen distal to the occlusion.
It will be recognized that the invention may be used to manufacture conduits the use of which is not limited to cardiovascular applications such as those illustrated and discussed above. For example, the invention may be used to produce conduits used to carry out many different bypass procedures, including, without limitation, femoral-femoral, femoral-popliteal, femoral-tibial, ilio-femoral, axillary-femoral, subclavian-femoral, aortic-bifemoral, aorto-iliac, aorto-profunda femoris and extra-anatomic. The conduit may be used to establish fluid communication with many different vessels, including, without limitation, the renal arteries, mesenteric vessel, inferior mesenteric artery, eroneal trunk, peroneal and tibial arteries. Still other applications for the invention include arteriovenous shunts. The conduit may have one, both or more ends configured to engage a target vessel for receiving blood from or delivering blood to another vessel.
The preferred embodiments of the invention are described above in detail for the purpose of setting forth a complete disclosure and for sake of explanation and clarity. It will be readily understood that the scope of the invention defined by the appended claims will encompass numerous changes and modifications.
This application is a continuation application of application Ser. No. 09/393,131, filed on Sep. 10, 1999, now abandoned which is a continuation-in-part of application Ser. No. 09/023,492, filed on Feb. 13, 1998, now abandoned application Ser. No. 09/232,103, filed on Jan. 15, 1999 now abandoned and application Ser. No. 09/232,062, filed on Jan. 15, 1999, now abandoned the entire disclosures of which are hereby incorporated by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2127903 | Bowen | Aug 1938 | A |
| 2453056 | Zack | Nov 1948 | A |
| 3042021 | Read | Jul 1962 | A |
| 3316914 | Collito | May 1967 | A |
| 3540451 | Zeman | Nov 1970 | A |
| 3774615 | Lim et al. | Nov 1973 | A |
| 3901965 | Honeyman, III | Aug 1975 | A |
| 3970401 | Lubeck | Jul 1976 | A |
| 3995617 | Watkins et al. | Dec 1976 | A |
| 4011872 | Komiya | Mar 1977 | A |
| 4072153 | Swartz | Feb 1978 | A |
| 4142528 | Whelan et al. | Mar 1979 | A |
| 4284459 | Patel et al. | Aug 1981 | A |
| 4300244 | Bokros | Nov 1981 | A |
| 4368736 | Kaster | Jan 1983 | A |
| 4400833 | Kurland | Aug 1983 | A |
| 4523592 | Daniel | Jun 1985 | A |
| 4546499 | Possis et al. | Oct 1985 | A |
| 4562597 | Possis et al. | Jan 1986 | A |
| 4581017 | Sahota et al. | Apr 1986 | A |
| 4712551 | Rayhanabad | Dec 1987 | A |
| 4728328 | Hughes et al. | Mar 1988 | A |
| 4769029 | Patel | Sep 1988 | A |
| 4769031 | McGough et al. | Sep 1988 | A |
| 4822341 | Colone | Apr 1989 | A |
| 4861330 | Vos | Aug 1989 | A |
| 4862886 | Clark et al. | Sep 1989 | A |
| 4873043 | Meyers | Oct 1989 | A |
| 4902289 | Yannes | Feb 1990 | A |
| 4953553 | Tremulis | Sep 1990 | A |
| 4955856 | Phillips | Sep 1990 | A |
| 4955899 | Della Corna et al. | Sep 1990 | A |
| 4976691 | Sahota | Dec 1990 | A |
| 4985014 | Orejola | Jan 1991 | A |
| 4995857 | Arnold | Feb 1991 | A |
| 5054484 | Hebeler, Jr. | Oct 1991 | A |
| 5071406 | Jang | Dec 1991 | A |
| 5078735 | Mobin-Uddin | Jan 1992 | A |
| 5100423 | Fearnot | Mar 1992 | A |
| 5106386 | Isner et al. | Apr 1992 | A |
| 5111832 | Saksena | May 1992 | A |
| 5131406 | Kaltenbach | Jul 1992 | A |
| 5143093 | Sahota | Sep 1992 | A |
| 5184610 | Marten et al. | Feb 1993 | A |
| 5190058 | Jones et al. | Mar 1993 | A |
| 5209731 | Sterman et al. | May 1993 | A |
| 5211624 | Cinberg et al. | May 1993 | A |
| 5250058 | Miller et al. | Oct 1993 | A |
| 5254097 | Schock et al. | Oct 1993 | A |
| 5254113 | Wilk | Oct 1993 | A |
| 5256150 | Quiachon et al. | Oct 1993 | A |
| 5275622 | Lazarus et al. | Jan 1994 | A |
| 5287861 | Wilk | Feb 1994 | A |
| 5302336 | Hartel et al. | Apr 1994 | A |
| 5314436 | Wilk | May 1994 | A |
| 5318527 | Hyde et al. | Jun 1994 | A |
| 5327193 | Date et al. | Jul 1994 | A |
| 5327913 | Taheri | Jul 1994 | A |
| 5330500 | Song | Jul 1994 | A |
| 5336176 | Yoon | Aug 1994 | A |
| 5356587 | Mitsui et al. | Oct 1994 | A |
| 5370685 | Stevens | Dec 1994 | A |
| 5380316 | Aita et al. | Jan 1995 | A |
| 5383892 | Cardon et al. | Jan 1995 | A |
| 5383925 | Schmitt | Jan 1995 | A |
| 5389096 | Aita et al. | Feb 1995 | A |
| 5395349 | Quiachon et al. | Mar 1995 | A |
| 5397320 | Essig et al. | Mar 1995 | A |
| 5409019 | Wilk | Apr 1995 | A |
| 5425705 | Evard et al. | Jun 1995 | A |
| 5425765 | Tiefenbrun et al. | Jun 1995 | A |
| 5429144 | Wilk | Jul 1995 | A |
| 5440551 | Suzuki | Aug 1995 | A |
| 5443497 | Venbrux | Aug 1995 | A |
| 5452733 | Sterman et al. | Sep 1995 | A |
| 5456714 | Owen | Oct 1995 | A |
| 5458574 | Machold et al. | Oct 1995 | A |
| 5466242 | Mori | Nov 1995 | A |
| 5478309 | Sweezer et al. | Dec 1995 | A |
| 5484418 | Quiachon et al. | Jan 1996 | A |
| 5488958 | Topel et al. | Feb 1996 | A |
| 5489295 | Piplani et al. | Feb 1996 | A |
| 5494041 | Wilk | Feb 1996 | A |
| 5501698 | Roth et al. | Mar 1996 | A |
| 5503635 | Sauer et al. | Apr 1996 | A |
| 5505725 | Samson | Apr 1996 | A |
| 5522880 | Barone et al. | Jun 1996 | A |
| 5549581 | Lurie et al. | Aug 1996 | A |
| 5591226 | Trerotola et al. | Jan 1997 | A |
| 5603722 | Phan et al. | Feb 1997 | A |
| 5613069 | Walker | Mar 1997 | A |
| 5620439 | Abela et al. | Apr 1997 | A |
| 5643340 | Nunokawa | Jul 1997 | A |
| 5649952 | Lam | Jul 1997 | A |
| 5653743 | Martin | Aug 1997 | A |
| 5655548 | Nelson et al. | Aug 1997 | A |
| 5662124 | Wilk | Sep 1997 | A |
| 5665114 | Weadock et al. | Sep 1997 | A |
| 5676670 | Kim | Oct 1997 | A |
| 5683640 | Miller et al. | Nov 1997 | A |
| 5689550 | Garson et al. | Nov 1997 | A |
| 5690656 | Cope et al. | Nov 1997 | A |
| 5695504 | Gifford, III et al. | Dec 1997 | A |
| 5697943 | Sauer et al. | Dec 1997 | A |
| 5702412 | Popov et al. | Dec 1997 | A |
| 5713950 | Cox | Feb 1998 | A |
| 5715818 | Swartz et al. | Feb 1998 | A |
| 5725553 | Moenning | Mar 1998 | A |
| 5755682 | Knudson et al. | May 1998 | A |
| 5755775 | Trerotola et al. | May 1998 | A |
| 5755778 | Kleshinski | May 1998 | A |
| 5758663 | Wilk et al. | Jun 1998 | A |
| 5782746 | Wright | Jul 1998 | A |
| 5797920 | Kim | Aug 1998 | A |
| 5797934 | Rygaard | Aug 1998 | A |
| 5797960 | Stevens et al. | Aug 1998 | A |
| 5799661 | Boyd et al. | Sep 1998 | A |
| 5800414 | Cazal | Sep 1998 | A |
| 5807243 | Vierra et al. | Sep 1998 | A |
| 5807384 | Mueller | Sep 1998 | A |
| 5810836 | Hussein et al. | Sep 1998 | A |
| 5814005 | Barra et al. | Sep 1998 | A |
| 5817113 | Gifford, III et al. | Oct 1998 | A |
| 5824042 | Lombardi et al. | Oct 1998 | A |
| 5824071 | Nelson et al. | Oct 1998 | A |
| 5827220 | Runge | Oct 1998 | A |
| 5829447 | Stevens et al. | Nov 1998 | A |
| 5830222 | Makower | Nov 1998 | A |
| 5830224 | Cohn et al. | Nov 1998 | A |
| 5836316 | Plaia et al. | Nov 1998 | A |
| 5843088 | Barra et al. | Dec 1998 | A |
| 5843165 | Plaia et al. | Dec 1998 | A |
| 5855210 | Sterman et al. | Jan 1999 | A |
| 5855597 | Jayaraman | Jan 1999 | A |
| 5871536 | Lazarus | Feb 1999 | A |
| 5875782 | Ferrari et al. | Mar 1999 | A |
| 5879321 | Hill | Mar 1999 | A |
| 5888201 | Stinson et al. | Mar 1999 | A |
| 5888247 | Benetti | Mar 1999 | A |
| 5893369 | Lemole | Apr 1999 | A |
| 5893886 | Zegdi et al. | Apr 1999 | A |
| 5895407 | Jayaraman | Apr 1999 | A |
| 5897587 | Martakos et al. | Apr 1999 | A |
| 5897589 | Cottenceau et al. | Apr 1999 | A |
| 5899934 | Amundson et al. | May 1999 | A |
| 5904697 | Gifford, III et al. | May 1999 | A |
| 5908028 | Wilk | Jun 1999 | A |
| 5908029 | Knudson et al. | Jun 1999 | A |
| 5910168 | Myers et al. | Jun 1999 | A |
| 5911753 | Schmitt | Jun 1999 | A |
| 5913894 | Schmitt | Jun 1999 | A |
| 5916226 | Tozzi | Jun 1999 | A |
| 5916264 | Von Oepen et al. | Jun 1999 | A |
| 5922019 | Hankh et al. | Jul 1999 | A |
| 5922022 | Nash et al. | Jul 1999 | A |
| 5925033 | Aita et al. | Jul 1999 | A |
| 5941893 | Saadat | Aug 1999 | A |
| 5941908 | Goldsteen et al. | Aug 1999 | A |
| 5944019 | Knudson et al. | Aug 1999 | A |
| 5959995 | Wicki et al. | Sep 1999 | A |
| 5968089 | Krajicek | Oct 1999 | A |
| 5971993 | Hussein et al. | Oct 1999 | A |
| 5972017 | Berg et al. | Oct 1999 | A |
| 5976178 | Goldsteen et al. | Nov 1999 | A |
| 5980567 | Jordan | Nov 1999 | A |
| 5984956 | Tweden et al. | Nov 1999 | A |
| 5989276 | Houser et al. | Nov 1999 | A |
| 5989278 | Mueller | Nov 1999 | A |
| 5989287 | Yang et al. | Nov 1999 | A |
| 5993489 | Lewis et al. | Nov 1999 | A |
| 6001124 | Bachinski | Dec 1999 | A |
| 6007544 | Kim | Dec 1999 | A |
| 6007576 | McClellan | Dec 1999 | A |
| 6017352 | Nash et al. | Jan 2000 | A |
| 6019788 | Butters et al. | Feb 2000 | A |
| 6029672 | Vanney et al. | Feb 2000 | A |
| 6030395 | Nash et al. | Feb 2000 | A |
| 6035856 | LaFontaine et al. | Mar 2000 | A |
| 6036705 | Nash et al. | Mar 2000 | A |
| 6053942 | Eno et al. | Apr 2000 | A |
| 6056762 | Nash et al. | May 2000 | A |
| 6063114 | Nash et al. | May 2000 | A |
| 6074416 | Berg et al. | Jun 2000 | A |
| 6076529 | Vanney et al. | Jun 2000 | A |
| 6080163 | Hussein et al. | Jun 2000 | A |
| 6092526 | LaFontaine et al. | Jul 2000 | A |
| 6093166 | Knudson et al. | Jul 2000 | A |
| 6102941 | Tweden et al. | Aug 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6123682 | Knudson et al. | Sep 2000 | A |
| 6139541 | Vanney et al. | Oct 2000 | A |
| 6143016 | Bleam et al. | Nov 2000 | A |
| 6148000 | Fedlman et al. | Nov 2000 | A |
| 6165185 | Shennib et al. | Dec 2000 | A |
| 6176864 | Chapman | Jan 2001 | B1 |
| 6179848 | Solem | Jan 2001 | B1 |
| 6190397 | Spence et al. | Feb 2001 | B1 |
| 6196230 | Hall et al. | Mar 2001 | B1 |
| 6197050 | Eno et al. | Mar 2001 | B1 |
| 6210430 | Solem | Apr 2001 | B1 |
| 6214041 | Tweden et al. | Apr 2001 | B1 |
| 6231587 | Makower | May 2001 | B1 |
| 6241741 | Duhaylongsod et al. | Jun 2001 | B1 |
| 6250305 | Tweden | Jun 2001 | B1 |
| 6251104 | Kesten et al. | Jun 2001 | B1 |
| 6251133 | Richter et al. | Jun 2001 | B1 |
| 6253768 | Wilk | Jul 2001 | B1 |
| 6253769 | LaFontaine et al. | Jul 2001 | B1 |
| 6254564 | Wilk et al. | Jul 2001 | B1 |
| 6293965 | Berg et al. | Sep 2001 | B1 |
| 6325813 | Hektner | Dec 2001 | B1 |
| 6352543 | Cole | Mar 2002 | B1 |
| 6402764 | Hendricksen et al. | Jun 2002 | B1 |
| 6443158 | LaFontaine et al. | Sep 2002 | B1 |
| 6517558 | Gittings et al. | Feb 2003 | B2 |
| 6537288 | Vargas et al. | Mar 2003 | B2 |
| 6635214 | Rapacki et al. | Oct 2003 | B2 |
| 6651670 | Rapacki et al. | Nov 2003 | B2 |
| 6652540 | Cole et al. | Nov 2003 | B1 |
| 6652541 | Vargas et al. | Nov 2003 | B1 |
| 6669708 | Nissenbaum et al. | Dec 2003 | B1 |
| 6701932 | Knudson et al. | Mar 2004 | B2 |
| 6719768 | Cole et al. | Apr 2004 | B1 |
| 6719781 | Kim | Apr 2004 | B1 |
| 6802847 | Carson et al. | Oct 2004 | B1 |
| 6808498 | Laroya et al. | Oct 2004 | B2 |
| 6955679 | Hendricksen et al. | Oct 2005 | B1 |
| 7017581 | Boyd et al. | Mar 2006 | B2 |
| 7025773 | Gittings et al. | Apr 2006 | B2 |
| 7027398 | Fang et al. | Apr 2006 | B2 |
| 7041110 | Yencho et al. | May 2006 | B2 |
| 7137962 | Gittings et al. | Nov 2006 | B2 |
| 7214234 | Rapacki et al. | May 2007 | B2 |
| 7285235 | Rapacki et al. | Oct 2007 | B2 |
| 20010004699 | Gittings et al. | Jun 2001 | A1 |
| 20010025643 | Foley | Oct 2001 | A1 |
| 20010041902 | Lepulu et al. | Nov 2001 | A1 |
| 20020004663 | Gittings et al. | Jan 2002 | A1 |
| 20020077566 | Laroya et al. | Jun 2002 | A1 |
| 20020144696 | Sharkawy et al. | Oct 2002 | A1 |
| 20020161424 | Rapacki et al. | Oct 2002 | A1 |
| 20020193782 | Ellis et al. | Dec 2002 | A1 |
| 20030158573 | Gittings et al. | Aug 2003 | A1 |
| 20040077987 | Rapacki et al. | Apr 2004 | A1 |
| 20040097988 | Gittings et al. | May 2004 | A1 |
| 20040113306 | Rapacki et al. | Jun 2004 | A1 |
| 20040134487 | Deem et al. | Jul 2004 | A1 |
| 20040154621 | Deem et al. | Aug 2004 | A1 |
| 20040167444 | Laroya et al. | Aug 2004 | A1 |
| 20040168691 | Sharkawy et al. | Sep 2004 | A1 |
| 20050043781 | Foley | Feb 2005 | A1 |
| 20050051163 | Deem et al. | Mar 2005 | A1 |
| 20050192604 | Carson et al. | Sep 2005 | A1 |
| 20070055344 | Gittings et al. | Mar 2007 | A1 |
| 20070233225 | Rapacki et al. | Oct 2007 | A1 |
| Number | Date | Country |
|---|---|---|
| 0121795 | Oct 1984 | EP |
| 0479478 | Apr 1992 | EP |
| 0515867 | Dec 1992 | EP |
| 0834287 | Apr 1998 | EP |
| 2316322 | Feb 1998 | GB |
| 736966 | May 1980 | SU |
| 1179978 | Sep 1985 | SU |
| 1754128 | Aug 1992 | SU |
| WO 8201644 | May 1982 | WO |
| WO 8402266 | Jun 1984 | WO |
| WO 8806865 | Sep 1988 | WO |
| WO 9015582 | Dec 1990 | WO |
| WO 9216141 | Oct 1992 | WO |
| WO 9300868 | Jan 1993 | WO |
| WO 9421197 | Sep 1994 | WO |
| WO 9533407 | Dec 1995 | WO |
| WO 9535065 | Dec 1995 | WO |
| WO 9600033 | Jan 1996 | WO |
| WO 9604854 | Feb 1996 | WO |
| WO 9604865 | Feb 1996 | WO |
| WO 9605773 | Feb 1996 | WO |
| WO 9622745 | Aug 1996 | WO |
| WO 9712555 | Apr 1997 | WO |
| WO 9713463 | Apr 1997 | WO |
| WO 9713471 | Apr 1997 | WO |
| WO 9727893 | Aug 1997 | WO |
| WO 9727897 | Aug 1997 | WO |
| WO 9727898 | Aug 1997 | WO |
| WO 9731464 | Aug 1997 | WO |
| WO 9732545 | Sep 1997 | WO |
| WO 9736453 | Nov 1997 | WO |
| WO 9806356 | Feb 1998 | WO |
| WO 9808456 | Mar 1998 | WO |
| WO 9816161 | Apr 1998 | WO |
| WO 9816174 | Apr 1998 | WO |
| WO 9819608 | May 1998 | WO |
| WO 9819614 | May 1998 | WO |
| WO 9819629 | May 1998 | WO |
| WO 9819630 | May 1998 | WO |
| WO 9819631 | May 1998 | WO |
| WO 9819634 | May 1998 | WO |
| WO 9819635 | May 1998 | WO |
| WO 9819636 | May 1998 | WO |
| WO 9823241 | Jun 1998 | WO |
| WO 9838939 | Sep 1998 | WO |
| WO 9838941 | Sep 1998 | WO |
| WO 9838942 | Sep 1998 | WO |
| WO 9838947 | Sep 1998 | WO |
| WO 9846115 | Oct 1998 | WO |
| WO 9846119 | Oct 1998 | WO |
| WO 9849964 | Nov 1998 | WO |
| WO 9855027 | Dec 1998 | WO |
| WO 9857590 | Dec 1998 | WO |
| WO 9857591 | Dec 1998 | WO |
| WO 9857592 | Dec 1998 | WO |
| WO 9917683 | Apr 1999 | WO |
| WO 9918887 | Apr 1999 | WO |
| WO 9921490 | May 1999 | WO |
| WO 9922658 | May 1999 | WO |
| WO 9925273 | May 1999 | WO |
| WO 9936000 | Jul 1999 | WO |
| WO 9936001 | Jul 1999 | WO |
| WO 9937349 | Jul 1999 | WO |
| WO 9938441 | Aug 1999 | WO |
| WO 9938454 | Aug 1999 | WO |
| WO 9938459 | Aug 1999 | WO |
| WO 9940868 | Aug 1999 | WO |
| WO 9948545 | Sep 1999 | WO |
| WO 9949793 | Oct 1999 | WO |
| WO 9949910 | Oct 1999 | WO |
| WO 9951162 | Oct 1999 | WO |
| WO 9953863 | Oct 1999 | WO |
| WO 9960941 | Dec 1999 | WO |
| WO 9962430 | Dec 1999 | WO |
| WO 9963910 | Dec 1999 | WO |
| WO 9965409 | Dec 1999 | WO |
| WO 0012020 | Mar 2000 | WO |
| WO 0015146 | Mar 2000 | WO |
| WO 0015147 | Mar 2000 | WO |
| WO 0015148 | Mar 2000 | WO |
| WO 0015149 | Mar 2000 | WO |
| WO 0015275 | Mar 2000 | WO |
| WO 0021436 | Apr 2000 | WO |
| WO 0024449 | May 2000 | WO |
| WO 0041633 | Jul 2000 | WO |
| WO 0021461 | Sep 2000 | WO |
| WO 0069364 | Nov 2000 | WO |
| WO 0074579 | Dec 2000 | WO |
| WO 0117440 | Mar 2001 | WO |
| WO 0139672 | Jun 2001 | WO |
| WO 0041633 | Jul 2001 | WO |
| Entry |
|---|
| Acuff, et al., Minimally Invasive Coronary Artery Bypass Grafting, Ann. Thorac. Surg., 1996,.61:135-137. |
| Ahmed, et al., Silent Left Coronary Artery—Cameral Fistula: Probably Cause of Myocardial Ischemia; Amer. Heart J., 1982, 104(4):869-870. |
| Ahn CY, Shaw WW, Berns S, et al., “Clinical Experience With the 3M Microvascular Coupling Anastomotic Device in 100 Free-Tissue Transfers,” Plastic and Reconstructive Surgery, Jun. 1994; 93(7):1481-1484. |
| Andrews et al., Assessment of Feasibility for Endovascular Prosthetic Tube Correction of Aortic Aneurysm, Brit. J. Surg., 1995, 82:917-919. |
| Antonatos, et al., Effect of the Positioning of a Balloon Valve in the Aorta on Coronary Flow during Aortic Regurgitation, J. Thorac. Cardiovas. Surg., Jul. 1984;88(1):128-133. |
| Arani, D., et al., Coronary Artery Fistulas Emptying into Left Heart Chamber, Amer. Heart J., 1978; 96(4):438-443. |
| Arom, et al., Patient Characteristics, Safety, and Benefits of Same-Day Admission for Coronary Artery Bypass Grafting, Ann. Thorac. Surg., 1996, 61:1136-1140. |
| Attai, et al, Aortic Valve Replacement in the Presence of Hufnagel Valve in the Descending Aorta, J. Thoracic Cardiovas. Surg., 1974, 68(1):112-115. |
| Baird, et al., Intramyocardial Pressure, A Study of its Regional Variations and its Relationship to Intraventricular Pressure, Journal of Thoracic and Cardiovascular Surgery, vol. 59, No. 6, Jun. 1970, pp. 810-823. |
| Beppu, et al., A Computerized Control System for Cardiopulmonary Bypass, J. Thoracic Cardiovas. Surg., 1995, 109(3):428-438. |
| Beyar, R., et al., Self-Expandable Nitinol Stent for Cardiovascular Applications, Catheterization and Cardiovascular Diagnosis, 1994; 32:162-170. |
| Binns, RL., et al., Optimal Graft Diameter: Effect of Wall shear Stress on Vascular Healing, J. Vasc. Surg., 1989; 10(3):326-337. |
| Black, et al., Multiple Coronary Artery—Left Ventricular Fistulae: Clinical, Angiographic, and Pathologic Findings, Cath. Cardio. Diag., 1991, 23:133-135. |
| Borst, C., et al., Coronary Artery Bypass Grafting Without Cardiopulmonary Bypass and Without Interruption of Native Coronary Flow Using a Novel Anastomosis Site Restraining Device (“Octopus ”), J. Am. Coll. Cardiol., 1996; 27:1356-64. |
| Buckberg, G.D., Update on Current Techniques of Myocardial Protection, Society Thorac. Surgeons, 1995, 60:805-814. |
| Buffolo, et al., Coronary Artery Bypass Grafting without Cardiopulmonary Bypass, Ann. Thorac. Surg., 1996, 61:63-66. |
| Butterfield, AB, et al., Inverse Effect of Chronically Elevated Blood Flow on Atherogenesis in Miniature Swine, Atherosclerosis, 1977; 26:215-224. |
| Cale, AJ, et al., Hufnagel Revisited: A Descending Thoracic Aortic Valve to Treat Prosthetic Valve Insufficiency, Ann. Thorac. Surg., 1993; 55:1218-21. |
| Campbell, CD, et al., A Small Arterial Substitute: Expanded Microporous Polytetrafluoroethylene: Patency Versus Porosity, Ann. Surg. 1975; 182:138-143. |
| Campeau, L., et al., Postoperative Changes in Aortocoronary Saphenous Vein Grafts Revisited, Circulation, 1975; 52:369-377. |
| Candinas, R., et al., Postmortem Analysis of Encapsulation Around Long-Term Ventricular Endorcardial Pacing Leads, Mayo Clin. Proc., 1999; 74:120-125. |
| Cercek, et al., Growth Factors in Pathogenesis of Coronary Arterial Restenosis, Amer. J. Cardio., 1991, 68:24C-33C. |
| Cha, et al., Silent Coronary Artery—Left Ventricular Fistula: a Disorder of the Thebesian System?, Angiology, 1978; 29(2):169-173. |
| Cha, S.D., Coronary Artery to Left Ventricular Fistula, Catheterization Cardio. Diag., 1991, 24:150. |
| Cheng, et al., Traumatic Aneurysm of Left Anterior Descending Coronary Artery with Fistulous Opening into Left Ventricle and Left Ventricular Aneurysm after Stab Wound of Chest, Amer. J. Card., 1973, 31:384-390. |
| Cheng, To.O., Left Coronary Artery-to-Left Ventricular Fistula: Demonstration of Coronary Steal Phenomenon, Amer. Heart J., 1982, 104(4):870-872. |
| Chia, et al., Coronary Artery—Left Ventricular Fistula, Cardiology, 1981, 68:167-179. |
| Connolly, et al., Cardiopulmonary Bypass and Intraoperative Protection, Heart Arteries Veins, 1994, 141:2443-2450. |
| Cooley, et al., Surgical Considerations of Coronary Arterial Fistula, Am. J. Cardiol., 1962, 10(4):467-474. |
| Cooper, CL and Miller A., Infectious Complications Related to the Use of the Angio-Seal Hemostatic Puncture Closure Device, Catheterization and Cardiovascular Interventions, 1999;.48:301-303. |
| Cuadros, L., One Hundred Percent Patency of One-Millimeter Polytetrafluoroethylene (Gore-Tex) Grafts in the Carotid Arteries of Rats, Microsurgery, 1984; 5:1-11. |
| Dake, et al., Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms, New England J. Med., 1994, 331(26):1729-1. |
| Daniel, RK, et al., An Anastomotic Device for Microvascular Surgery: Evolution, Annals of Plastic Surgery, 1984; 13(5):402-411. |
| DeLacure, MD, et al., Clinical Experience in End-to-Side Vernous Anastomoses With a Microvascular Anastomotic Coupling Device in Head and Neck Reconstruction, Arch. Otolaryngol. Head Neck Surg., 1999; 125:869-872. |
| Dolmatch, BL, et al., Tissue Response to Covered Wallstents, JVIR, 1998; 9(3):471-478. |
| du Plessis, et al., Aortic Valve Replacement in the Presence of a Hufnagel Valve Prosthesis, J. Thoracic Cardiovs. Surg., 1996, 51(4):493-497. |
| Elian, D., Left Coronary Artery to Left Ventricular Fistual Can Result in a Coronary Steal, Catheterization Cardiovas. Diag., 1998, 43:490. |
| Emery, RW, et al., Operative Considerations in Implantation of the Perma-Flow Graft, Ann. Thorac. Surg., 1994; 58:1770-73. |
| Emery, RW, et al., North American Experience With the Perma-Flow Prosthetic Coronary Graft, Ann. Thorac. Surg., 1996; 62:691-96. |
| Emery, RW, et al., First Clinical Use of the Possis Synthetic Coronary Graft, J. Card. Surg., 1993; 8:439-442. |
| Esquivel, CO, et al., Reduced Thrombogenic Characteristics of Expanded Polytetrafluoroethylene and Polyurethane Arterial Grafts After Heparin Bonding, Surgery, 1984; 95(1):102-107. |
| Flynn, et al., Does systolic Subepicardial Perfusion come from Retrograde Subendocardial Flow?, Amer. Physiological Society, 1992, 262: pp. 1759-1769. |
| Galioto, FM, et al., Right Coronary Artery to Left Ventricle Fistula, Amer. Heart J., 1971; 82(1):93-97. |
| Gentile, AT, et al., Vein Patching Reduces Neointimal Thickening Associated with Prosthetic Graft Implantation, Am. J. Surg., 1998; 176:601-607. |
| Gitter, et al., Influence of Ascending Versus Descending Balloon Counterpulsation on Bypass Graft Blood Flow, Ann. Thorac. Surg., 1998, 65:365-370. |
| Goldman, et al., Experimental Methods for Producing a Collateral Circulation to the Heart Directly from the Left Ventricle, J. Thoracic Surg., 1956, 31(3):364-374. |
| Green, et al., The Phasic Changes in Coronary Flow Established by Differential Pressure Curves, Department of Physiology, Western Reserve University, Cleveland, Ohio, May 6, 1935, pp. 627-639. |
| Gregg, et al., Measurements of Intramyocardial Pressure, Department of Medicine, Western Reserve University School of Medicine, Cleveland, Ohio, Oct. 21, 1940, pp. 781-790. |
| Guyton, RA, et al., A Mechanical Device for Sutureless Aorta-Saphenous Vein Anastomosis, Ann. Thoracic Surg., 1979; 28(4):342-345. |
| Halkier, et al., Aortic Incompetence: The Eventual Outcome in a Small Series Treated with Hufnagel 's Descending Aorta Ball-valve, Scand. J. Thor. Cardiovasc. Surg., 1970, 4:52-55. |
| Harada, et al., VEGF in Chronic Myocardial Ischemia, Amer. Physiol. Soc., 1996, H1791-H1801. |
| Haravon, et al., Congenital Coronary Artery to Left Ventricle Fistula with Angina Pectoris, N.Y. State J. Med., 1972, pp. 2196-2200. |
| Hausdorf, et al., Radiofrequency-assisted “Reconstruction” of the Right Ventricular Outflow Tract in Muscular Pulmonary Atresia with Ventricular Septal Defect, Br. Heart J., 1993, 69:343-346. |
| Heijmen, RH, et al., Temporary Luminal Arteriotomy Seal: II. Coronary Artery Bypass Grafting on the Beating Heart, Ann. Thorac. Surg., 1998; 66:471-476. |
| Hofma, et al., Increasing Arterial Wall Injury after Long-term Implantation of Two Types of Stent in a Porcine Coronary Model, Eur. Heart. J., 1998, 19:601-609. |
| Hongo, et al., Effects of Heart Rate on Phasic Coronary Blood Flow Pattern and Flow Reserve in Patients with Normal Coronary Arteries: A Study with an Intravascular Doppler Catheter and Spectral Analysis, Amer. Heart J., 1994, 127(3):545-551. |
| Houki, et al., A Stimulation Study of Coronary Circulatory System, Jap. Cir. J., 1977, 41:1279-1280. |
| Hufnagel, et al., Surgical Correction of Aortic Insufficiency, Surgery, 1954, 35(5):673-683. |
| Hutchins, et al., Aterial-venous Relationships in the Human Left Ventricular Myocardium, Anatomoic Basis for Countercurrent Regulation of Blood Flow, Circulation, vol. 74, No. 6, Dec. 1986, pp. 1195-1202. |
| Ilia, R., Coronary Angiography in Dextrocardia, Catheterization Cardio. Diag., 1991, 24 p. 150. |
| Jamieson, S.W., Aortocoronary Saphenous Vein Bypass Grafting, Operative Surgery, 4th Edition, pp. 454-470. |
| Kaiser, et al., Video-Assisted Thoracic Surgery: The Current State of the Art, AJR, 1995, 165:1111-1117. |
| Kajiya, et al., Endocardial Coronary Microcirculation of the Beating Heart, Interactive Phenomena in the Cardiac System, 1993, pp. 173-180. |
| Kajiya, et al., Mechanical Control of Coronary Artery Inflow and Vein Outflow, Jap. Cir. J., 1989, 53:431-438. |
| Kajiya, et al., Velocity Profiles and Phasic Flow Patterns in the Non-stenotic Human Left Anterior Descending Coronary Artery During Cardiac Surgery, Cardiovasc. Research, 1993, 27:845-850. |
| Kohmoto, et al., Does Blood Flow through Holmium: YAG Transmyocardial Laser Channels?, Ann. Thorac. Surg., 1996, 61:861-868. |
| Koyama, T el al., Non-uniform Oxygen Supply to the Left Ventricular Myocardium by Systolic Perfusion of Coronary Artery, Japanese J of Physiology, 1979, 29, 267-274. |
| Louagie et al., Operative Risk assessment in Coronary Artery Bypass Surgery, 1990-1993 : Evaluation of Perioperative Variables, Thorac. Cardiovasc. Surg., 1995; 43:134-141. |
| Marin, et al., Initial Experience with Transluminally Placed Endovascular Grafts for the Treatment of Complex Vascular Lesions, Annals of Surg., 1995, 222(4):449469. |
| Massimo, et al., Myocardial Revascularization by a New Method of Carrying Blood Directly from the Left Ventricular Cavity into the Coronary Circulation, Journal of Thoracic and Cardiovascular Surgery, vol. 34, No. 2, Aug. 1957, pp. 257-265. |
| Matsumae M et al., An Experimental Study of New Sutureless Intraluminal Graft With an Elastic Ring That Can Attach Itself to the Vessel Wall, J. Vasc. Surg., 1988;8:33-44. |
| McLellan BA et al., Myocardial Infarction Due to Multiple Coronary—Ventricular Fistulas. Catheterization and CardioVascular Diagnosis, 1989;16:247-249. |
| McNamara, et al., Congenital Coronary Artery Fistula, Surgery, 1969, 65(1):59-69. |
| Midell, et al., Surgical Closure of Left Coronary Artery—Left Ventricular Fistula, J. Thorac. Cardiovas. Surg., 1997, 2:199-203. |
| Milano, et al., Mediastinitis after Coronary Artery Bypass Graft Surgery, Circulation, 1995, 92(8):2245-2251. |
| Mirhoseini, et al., Myocardial Revascularization by Laser: A Clinical Report, Lasers in Surg. Med., 1983, 3:241-245. |
| Mirhoseini, et al., New Concepts in Revascularization of the Myocardium, Ann. Thorac. Surg., 1988, 45:415-420. |
| Munro, et al., The Possibility of Myocardial Revascularization by Creation of a Left Ventriculocoronary Artery Fistula, Journal of Thoracic and Cardiovascular Surgery, vol. 58, No. 1, Jul. 1969, pp. 25-32. |
| Nishida, et al., Flow Study of Surgical Coronary Artery Fistula as an Alternative to Sequential Bypass, Cariovascular Surg., 1995, 3(4):375-380. |
| Nollert, et al., Use of the Internal Mammary Artery as a Graft in Emergency Coronary Artery Bypass Grafting after Failed PTCA, Thorac. Cardiovasc. Surg., 1995, 43:142-147. |
| O'Connor, et al., Ventriculocoronary Connections in Hypoplatic Left Hearts: An Autopsy Microscopic Study, Circulation, 1982, 66(5):1078-1086. |
| Obora, et al., Nonsuture Microvascular Anastomosis Using Magnet Rings, Neurol. Med. Chir., 1980, 20: pp. 497-505. |
| Obora, et al., Nonsuture Microvascular Anastomosis Using Magnet Rings: Preliminary Report, Surg. Neurol—1978 vol. 9: 117-120. |
| Okuda, et al., Right Coronary Artery to Left Ventricle Fistula, Jap. Heart J., 1973, 14(2):184-191. |
| Pelletier, et al., Angiogenesis and Growth Factor Expression in a Model of Transmyocardial Revascularization, Ann of Thorac. Surg., 1998, 66:12-18. |
| Petropoulakis, et al., Changes in Phasic Coronary Blood Flow Velocity Profile in Relation to Changes in Hemodynamic Parameters during Stress in Patients with Aortic Valve Stenosis, Circulation, 1995, 92(6):1437-1447. |
| Pifarre, et al., Myocardial Revascularization by Transmyocardial Acupuncture, A Physiologic Impossibility, Journal of Thoracic and Cardiovascular Surgery, vol. 58, No. 3, Sep. 1969, pp. 424-431. |
| Pifarre, et al., Myocardial Revascularization from the Left Ventricle: A Physiological Impossibility, Surgical Forum, 1968, 19:157-159. |
| Reddy, et al., Multiple Coronary Arteriosystemic Fistulas, Amer. J. Cardiol., 1974, 33:304-306. |
| Roe, et al., Experimental Results with a Prosthetic Aortic Valve, J. Thoracic Surg., 1958, 36(4):563-570. |
| Roe, et al., The Subcoronary Implantation of a Flexible Triscupid Aortic Valve Prosthesis, J. Thorac. Cardiovs. Surg., 1960, 40(5):561-567. |
| Ryan, et al., Fistula from Coronary Arteries to Left Ventricle after Myocardial Infarction, Brit. Heart J., 1977, 39:1147-1149. |
| Salzmann, DL, et al., Effects of Balloon Dilatation on ePTFE Structural Characteristics, J. Biomed. Mater. Res., 1997; 36:498-507. |
| Salzmann, DL, et al., Healing Response Associated with Balloon-dilated ePTFE, J. Biomed. Mater. Res., 1998; 41:364-370. |
| Sastri, et al., Coronary Artery Left Ventricular Fistula, Chest, 1975, 68(5):735-736. |
| Scheltes, et al., Assessment of Patented Coronary End-to-Side Anastomotic Devices Using Micromechanical Bonding, Ann. Thorac. Surg., 2000, 70:218-221. |
| Schneider, t al., Transcatheter Radiofrequency Perforation and Stent Implantation for Palliation of Pulmonary Atresiain a 3060-g Infant, Catheterization Cardiovas. Diag., 1995, 34:42-45. |
| Schwartz, et al., Minimally Invasive Cardiopulmonary Bypass with Cardioplegic Arrest: A Closed Chest Technique with Equivalent Myocardial Protection, J. Thorac. Cardiovasc. Surg., 1996, 111:556,566. |
| Segal, et al., Alterations of Phasic Coronary Artery Flow Velocity in Humans During Percutaneous Coronary Angioplasty, JACC, 1992, 20(2):276-286. |
| Sen, et al., Transmyocardial Acupuncture, A New Approach to Myocardial Revascularization, Journal of Thoracic and Cardiovascular Surgery, vol. 50, No. 2, Aug. 1965, pp. 181-189. |
| Sheikhzadeh A et al., Generalized Coronary Arterio-Systemic (left ventricular)fistula. Jpn. Heart J., 1986;27(4:533-544. |
| Sigwart, U., An Overview of Intravascular Stents: Old and New, pp. 803-815. |
| Silvay, et al., Cardiopulmonary Bypass for Adult Patients: A Survey of Equipment and Techniques, J. Cardiothoracic Vas. Anetsh., 1995, 9(4):420-424. |
| Stefanadis, C., et al., Stents Covered by an Autologous Arterial Graft in Porcine Coronary Arteries: Feasibility, Vascular Injury and Effect on Neointimal Hyperplasia, Cardiovascular Research, 1999; 41:433-442. |
| Stevens, et al., Port-Access Coronary Artery Bypass Grafting: A Proposed Surgical Method, J. Thorac. Cardiovasc. Surg., 1996, 111(3):567-573. |
| Taylor, KM, Brain Damage During Cardiopulmonary Bypass, Ann. Thorac. Surg., 1998; 65:S20-6. |
| Vierra, M., Minimally Invasive Surgery, Annu. Rev. Med., 1995, 46:147-158. |
| Vineberg, Coronary Vascular Anastomoses by Internal Mammary Artery Implantation, Review Article, vol. 78, Jun. 1, 1958, pp. 871-879. |
| Vineberg, et al., Treatment of Acute Myocardial Infarction by Endocardial Resection, Surgery, 1965, 57(6):832-835. |
| von Segesser, L.K., Arterial Grafting for Myocardial Revascularization, 1990, pp. 3-140. |
| Vongpatanasin, et al., Prosthetic Heart Valves, New England J. Medicine, 1996, 335(6):407-416. |
| Waller, et al., The Pathology of Interventional Coronary Artery Techniques and Devices, Topol's Texbook of Interventional Cardiology 1994 pp. 449-476. |
| Wearn, et al., The Nature of the Vascular Communications Between the Coronary Arteries and the Chambers of the Heart, The American Heart Journal, vol. IX, No. 2, Dec. 1933, pp. 143-164. |
| Whittaker, et al., Transmural Channels Can Protect Ischemic Tissue, Circulation, 1996, 93(1):143-152. |
| Wolfe, et al., Fistules Coronaro-Ventriculaires Gauches, Mal. Coéur., 1981, 74(11):1353-1357. |
| Number | Date | Country | |
|---|---|---|---|
| 20040168691 A1 | Sep 2004 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 09393131 | Sep 1999 | US |
| Child | 10778723 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 09023492 | Feb 1998 | US |
| Child | 09393131 | US | |
| Parent | 09232103 | Jan 1999 | US |
| Child | 09023492 | US | |
| Parent | 09232062 | Jan 1999 | US |
| Child | 09232103 | US |
